Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer

por Molto Valiente, Consolacion, Amir, Eitan
Publicado 2023

Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer

por Mittal, Abhenil, Molto Valiente, Consolacion, Tamimi, Faris, Schlam, Ilana, Sammons, Sarah, Tolaney, Sara M., Tarantino, Paolo
Publicado 2023

Clinical benefit of cancer drugs approved in Switzerland 2010–2019

por Adam, Roman, Tibau, Ariadna, Molto Valiente, Consolación, Šeruga, Boštjan, Ocaña, Alberto, Amir, Eitan, Templeton, Arnoud J.
Publicado 2022

Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis

por Mittal, Abhenil, Molto Valiente, Consolacion, Tamimi, Faris, Di Iorio, Massimo, Al-Showbaki, Laith, Cescon, David W, Amir, Eitan
Publicado 2023